Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Department at the UFS receives special visitors
2008-02-26

 

From the left are: Prof. Hans Ausloos, Prof. Bénédicte Lemmelijn, and Prof. Fanie Snyman (Head of the Department of Old Testament at the UFS). Both Prof. Ausloos and Prof. Lemmelijn are professors in the Old Testament within the Bible Science Investigation Unit of the Katholieke Universiteit Leuven in Belgium.
Photo: Lacea Loader
 

Department at the UFS receives special visitors

The Department of Old Testament in the Faculty of Theology at the University of the Free State (UFS) has for the first time received a visit from two guest professors from the Katholieke Universiteit Leuven (KU) in Belgium who are presenting undergraduate lectures.

What makes the visit even further unique is that the guest professors are a married couple who specialise in the Old Testament.

“Proff. Hans Ausloos and Bénédicte Lemmelijn are visiting the faculty for about a month to present undergraduate programmes. They are part of a co-operative agreement between the UFS and the KU Leuven. This is also a good way of giving our students exposure to European experts,” says Prof. Snyman, Head of the Department of Old Testament at the UFS.

The couple and their three children, Matthias (10), Elke (8) and Ruben (6), are staying in Prof. Daan Pienaar’s house for the duration of their stay. Prof. Pienaar is a retired professor in Biblical Science at the UFS. The children are at school in Universitas Primary School for the duration of the family’s stay in Bloemfontein. “The headmaster was very kind and provided them with school uniforms out of the school’s second hand clothing shop, of which they will not part easily as they do not wear school uniform in Belgium,” says Prof. Lemmelijn.

Proff. Lemmelijn and Ausloos cannot stop talking about the charm of the university’s Main Campus. “In Leuven the university is part of the city and the university buildings are situated amongst the city buildings. We do our shopping while the students move from one class to the other! Here, the university is a town on its own and the students are given the opportunity to socialise in a protected environment,” says Prof. Lemmelijn.

The couple is also just as impressed with Bloemfontein. “The safety issue in South Africa is accentuated in such a way in Europe that we are astounded by the peaceful and friendly atmosphere of the city. We are also surprised with the shopping centres that are under one roof. In Belgium the shops are situated far apart,” says Prof. Lemmelijn.

The couple finds the living costs – especially food – to be quite expensive. “Some basic food is even more expensive than it is in Belgium,” says Prof. Ausloos.

Over and above their commitment to lecture, the couple is also busy with research on the Greek translation of the 12 Small Prophets in co-operation with Prof. Snyman.

“This is the first time that lecturers from the KU Leuven visit the Department of Old Testament for such a long time and are part of the normal curriculum. It is interesting to note that the teaching modules between the two departments resemble each other in such a way that lectures which are presented in Leuven are also repeated here,” says Prof. Snyman.

Both Proff. Ausloos and Lemmelijn are professors in the Old Testament within the Bible Science Investigation Unit of the KU Leuven. They publish articles internationally on the editorial and text criticism of the Old Testament and are involved with international investigative programmes such as the Hexapla Project and Septuaginta-Deutsch. Prof. Ausloos is director of the Leuvense Centre for Septuagint Studies and Textual Criticism and Prof. Lemmelijn is an associate in the centre. Together they have published several financed investigative projects on the characterising of the translation technique of the Greek Bible translation.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
25 February 2008
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept